Related Experiment Video
Updated: Aug 17, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
Published on: December 3, 2013
Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors
John Nemunaitis1, Casey Cunningham
1US Oncology, Mary Crowley Medical Research Center, Baylor University Medical Center, 3535 Worth Street, Collins Building, 5th Floor, Dallas, TX 75246, USA.
Abstract:
The treatment of cancer by genetic manipulation of either the tumor itself or the patient as a whole offers new avenues for the treatment of otherwise refractory cancers. Gene therapy seeks to correct underlying genetic defects in malignant tissue or to augment the host defense response or to promote selectivity of other therapies. Many innovative and exciting genetic targets have been recently identified. However, the field as a whole is still constrained by limitations of gene delivery. The most common vector for gene delivery is modified adenovirus. In this review, we survey a sampling of current therapeutic approaches that depend upon adenoviral delivery vehicles and outline the advantages and disadvantages of this vector system.
Insights
Gene therapy offers new cancer treatment options by genetically modifying tumors or patients. Modified adenoviruses are common delivery vectors, but gene delivery limitations remain a challenge.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Cancer treatment is evolving with genetic manipulation strategies.
- Gene therapy aims to correct genetic defects or enhance immune responses against cancer.
- Identifying novel genetic targets is crucial for advancing cancer therapies.
Purpose of the Study:
- To review current gene therapy approaches for cancer.
- To focus on therapeutic strategies utilizing adenoviral delivery vehicles.
- To analyze the advantages and disadvantages of adenoviral vectors in gene therapy.
Main Methods:
- Survey of current therapeutic approaches using adenoviral gene delivery.
- Analysis of the benefits and drawbacks of adenoviral vector systems.
- Literature review of gene therapy applications in oncology.
Main Results:
- Gene therapy presents promising avenues for refractory cancers.
- Adenovirus is a frequently used vector for gene delivery in cancer therapy.
- Limitations in gene delivery persist despite innovative targets.
Conclusions:
- Adenoviral vectors are pivotal in current gene therapy for cancer.
- Understanding adenoviral vector limitations is key to improving gene delivery.
- Further research is needed to overcome gene delivery challenges in cancer gene therapy.
Related Concept Videos
Gene Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics

